drugset / Trial / NCT00465907
Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer
NaSingle-groupOpen-labelTreatment
Summary
Evaluate the efficacy and toxicity of the weekly combination chemotherapy of Paclitaxel, Carboplatin and Irinotecan in Stage IIIb and IV NSCLC with malignant pleural effusion
Timeline
- Start
- 2003-05
- Primary completion
- 2008-03
- Completion
- 2014-02
Outcome
Outcome not reported
Stopped (Enrollment): “Low accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | — |
| Subject | Irinotecan | Small molecule | 60 mg/m2 | — |
| Subject | Paclitaxel | Small molecule | 60 mg/m2 | — |